ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $707,032 | -33.7% | 26,313 | -42.6% | 0.03% | +39.1% |
Q2 2023 | $1,066,546 | +266.8% | 45,804 | +71.9% | 0.02% | +76.9% |
Q1 2023 | $290,786 | +88017.0% | 26,653 | -9.4% | 0.01% | +44.4% |
Q4 2022 | $330 | -99.9% | 29,417 | +19.8% | 0.01% | +28.6% |
Q3 2022 | $277,000 | +3.7% | 24,560 | +3.2% | 0.01% | -12.5% |
Q2 2022 | $267,000 | -47.3% | 23,789 | -47.5% | 0.01% | +33.3% |
Q1 2022 | $507,000 | -64.4% | 45,308 | +110.9% | 0.01% | -78.6% |
Q4 2021 | $1,424,000 | +6.3% | 21,482 | +0.3% | 0.03% | +3.7% |
Q3 2021 | $1,340,000 | -22.7% | 21,412 | +2.5% | 0.03% | -25.0% |
Q2 2021 | $1,734,000 | +41.2% | 20,895 | +12.9% | 0.04% | +50.0% |
Q1 2021 | $1,228,000 | -14.0% | 18,503 | -0.5% | 0.02% | -58.6% |
Q4 2020 | $1,428,000 | +70.0% | 18,598 | -4.7% | 0.06% | +16.0% |
Q3 2020 | $840,000 | +5.8% | 19,522 | +5.0% | 0.05% | -20.6% |
Q2 2020 | $794,000 | +50.1% | 18,589 | +8.0% | 0.06% | +18.9% |
Q1 2020 | $529,000 | -38.8% | 17,207 | +29.4% | 0.05% | -18.5% |
Q4 2019 | $864,000 | +70.1% | 13,297 | -29.6% | 0.06% | +91.2% |
Q3 2019 | $508,000 | +134.1% | 18,896 | +3.7% | 0.03% | +161.5% |
Q4 2018 | $217,000 | +274.1% | 18,216 | +507.2% | 0.01% | +550.0% |
Q3 2018 | $58,000 | +190.0% | 3,000 | +100.0% | 0.00% | +100.0% |
Q2 2018 | $20,000 | +100.0% | 1,500 | -21.1% | 0.00% | 0.0% |
Q2 2016 | $10,000 | – | 1,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |